Toggle light / dark theme

Official Ending Age-Related Diseases Press Release

The Life Extension Advocacy Foundation, a nonprofit organization dedicated to promoting healthy longevity and aging research through crowdfunding and advocacy initiatives, is hosting its second annual scientific conference, Ending Age-Related Diseases: Investment Prospects and Advances in Research, at the Cooper Union in New York City on July 11th-12th.

The goal of this conference is to promote collaboration between academia, biotech companies, investors, regulators, public health advocates, and doctors in order to foster the creation of interventions to relieve our aging society from the burden of age-related diseases. It is supported by Genome Protection Inc., which is developing therapies to counteract harmful viral elements in our genome that provoke chronic inflammation, and Icaria Life Sciences Inc., which provides contract research in the field of geroscience.

The morbidity from chronic age-related diseases is increasing proportionally to the aging of the global population, representing a challenge to social protection and healthcare systems around the world. The development of next-generation drugs and therapies that could directly target the processes of aging to more effectively prevent and cure age-related diseases has now become a priority, yet the industry is clearly facing unique financial, development, and regulatory bottlenecks.

The Scientist Who Believes We Can Reverse Aging | Dr. Aubrey de Grey ►Rob Konrad: Conversations #010

Dr Aubrey de Grey doesn’t just believe that aging, and the suffering that comes with it, can be slowed down — he believes it can be undone altogether.

What’s more, he thinks we are merely a few years away from making the scientific breakthroughs that will enable the medical field to put an end to death related to ageing — for good.

His independently funded non-profit, the SENS Foundation, is at the forefront of radical research that combines the problem solving approaches of technology with geriatric medicine.

In this conversation, he talks to Rob about his refusal to age gracefully, the biases of modern science, immortality, and why he won’t waste his time thinking about whether or not God exists.

▶▶ NEW EPISODE EVERY WEDNESDAY!

Quantum Particles Found Exhibiting Immortality Through “Infinite Decay And Rebirth”

We know that the rule “nothing lasts forever” holds true for everything. But the world of quantum particles doesn’t always seem to follow the rules.

In the latest findings, scientists have observed that quasiparticles in quantum systems could be virtually immortal. These particles can regenerate themselves after they have decayed — and this can have a significant impact on the future of quantum computing and humanity itself.

This finding stands up directly against the second law of thermodynamics which basically says that things can only break down and not reconstruct again. However, these quantum particle fields can reconstruct themselves after decaying – just like the Phoenix rises from its ashes in Greek mythology.

David Sinclair — Cracking & reversing the aging clock — Science Unlimited 2019

Renowned longevity researcher David Sinclair believes aging is not inevitable but a treatable condition. In his talk at Science Unlimited 2019, he explained why we age – and how we can reverse aging to extend human healthspan and lifespan.

David Sinclair is Professor in the Department of Genetics, Blavatnik Institute and co-Director of the Paul F. Glenn Center for the Biological Mechanisms of Aging at Harvard Medical School. Science Unlimited is held in Montreux, Switzerland, as part of the annual Frontiers Forum. See all speakers: https://forum.frontiersin.org

Deep Aging Clocks: The Emergence of AI-Based Biomarkers of Aging and Longevity

First published in 2016, predictors of chronological and biological age developed using deep learning (DL) are rapidly gaining popularity in the aging research community.

These deep aging clocks can be used in a broad range of applications in the pharmaceutical industry, spanning target identification, drug discovery, data economics, and synthetic patient data generation. We provide here a brief overview of recent advances in this important subset, or perhaps superset, of aging clocks that have been developed using artificial intelligence (AI).

David Sinclair Is Extending Human Lifespan | Rich Roll Podcast

David Sinclair PhD is a biologist and Professor of Genetics at Harvard Medical School, co-director of the Paul F. Glenn Center for the Biological Mechanisms of Aging and author of the forthcoming book “Lifespan: The Revolutionary Science of Why We Age — and Why We Don’t Have To”.

This conversation is about the science behind aging and David’s research on the biology of lifespan extension, treating diseases of aging and extending human lifespan.

Note — this is AUDIO ONLY (we didn’t film this podcast)

Enjoy!
✌🏼🌱 — Rich

PODCAST, BLOG & SHOW NOTES
http://bit.ly/richroll436

DAVID SINCLAIR, PhD

Aging is associated with a systemic length-driven transcriptome imbalance

Aging manifests itself through a decline in organismal homeostasis and a multitude of cellular and physiological functions. Efforts to identify a common basis for vertebrate aging face many challenges; for example, while there have been documented changes in the expression of many hundreds of mRNAs, the results across tissues and species have been inconsistent. We therefore analyzed age-resolved transcriptomic data from 17 mouse organs and 51 human organs using unsupervised machine learning3 5 to identify the architectural and regulatory characteristics most informative on the differential expression of genes with age. We report a hitherto unknown phenomenon, a systemic age-dependent length-driven transcriptome imbalance that for older organisms disrupts the homeostatic balance between short and long transcript molecules for mice, rats, killifishes, and humans. We also demonstrate that in a mouse model of healthy aging, length-driven transcriptome imbalance correlates with changes in expression of splicing factor proline and glutamine rich (Sfpq), which regulates transcriptional elongation according to gene length. Furthermore, we demonstrate that length-driven transcriptome imbalance can be triggered by environmental hazards and pathogens. Our findings reinforce the picture of aging as a systemic homeostasis breakdown and suggest a promising explanation for why diverse insults affect multiple age-dependent phenotypes in a similar manner.

The transcriptome responds rapidly, selectively, strongly, and reproducibly to a wide variety of molecular and physiological insults experienced by an organism. While the transcripts of thousands of genes have been reported to change with age, the magnitude by which most transcripts change is small in comparison with classical examples of gene regulation2,8 and there is little consensus among different studies. We hence hypothesize that aging is associated with a hitherto uncharacterized process that affects the transcriptome in a systemic manner. We predict that such a process could integrate heterogenous, and molecularly distinctive, environmental insults to promote phenotypic manifestations of aging.

We use an unsupervised machine learning approach3 5 to identify the sources of age-dependent changes in the transcriptome. To this end, we measure and survey the transcriptome of 17 mouse organs from 6 biological replicates at 5 different ages from 4 to 24 months raised under standardized conditions (Fig. 1A). We consider information on the structural architecture of individual genes and transcripts, and knowledge on the binding of regulatory molecules such as transcription factors and microRNAs (miRNAs) (Fig. 1B). We define age-dependent fold-changes as the log2-transformed ratio of transcripts of one gene at a given age relative to the transcripts of that gene in the organs of 4-month-old mice. As expected for models capturing most measurable changes in transcript abundance, the predicted fold-changes (Fig. S1) match changes empirically observed between distinct replicate cohorts of mice (Figs. S2 and S3).

/* */